Brian McHugh

22 POSTS 0 COMMENTS

STEVECO trial catalyzes need for “a new era” of post-thrombotic syndrome...

This advertorial is sponsored by Optimed. Before the STEVECO trial, there were no randomized controlled trial data in the chronic disease space; in its wake, has...

Philips launches Duo venous stent system for treatment of symptomatic venous...

Royal Philips today announced the first implant of the Duo venous stent system, an implantable medical device indicated to treat symptomatic venous outflow obstruction...

CX panel confronts conundrum of the moment: Should NIVL patients get...

Should non-thrombotic iliac vein lesion (NIVL) patients be given venous stents? That was the question raised to Gerry O’Sullivan (Galway, Ireland), a consultant interventional...

Gloria Salazar

“There are a lot of patients walking out there who are not being treated. So you can only imagine the impact that we can...

“The forgotten stepchild of vascular surgery”: The quest to push forward...

The 2024 Venous Symposium (May 8–11, New York City, USA) was highlighted by keynote speaker Peter Pappas (Chester, USA), regional medical director and program...

Catheter-directed mechanical thrombectomy system demonstrates safety and effectiveness in patients with...

Results from Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AX) finds significant improvement in right ventricle function and minimal major adverse events. New...

Women and black patients less likely to receive catheter-based treatment for...

New data from the REAL-PE analysis investigated catheter-based pulmonary embolism (PE) treatment, showing women and Black people were less frequently treated with minimally invasive...

Novel thrombectomy system demonstrates positive safety and feasibility results in treating...

Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE). The...

JVS-VL papers go under the microscope

On the final day of the 2024 International Vein Congress (April 18–20) in Miami, Florida, Joseph P. Hart, MD, associate professor of surgery and...

VVT Medical Receives Approval from Korean Ministry of Food and Drug...

VVT Medical has announced the completion of GMP certification and registration of Novel Non-Thermal, Anesthesia- free treatment for Varicose veins. This milestone approval adds...

IVC 2024: When are lymphedema pumps the answer?

The importance of activating the calf muscle pump in the treatment of lower extremity lymphedema came to the fore during the 2024 International Vein...

New randomized controlled data from VenaSeal Spectrum Program reinforces evidence that...

  “The initial results of two of the three studies in the VenaSeal Spectrum Program reinforce the safety and effectiveness of the VenaSeal system as...

IVC 2024: Next-generation venous devices take center stage

During the 2024 International Venous Conference (April 18-20) in Miami, Florida, Lowell Kabnick, MD (Lake Worth Beach, Florida), gave s presentation on the newest...

IVC 2024: Choosing the right stent for the right situation

Patrick Muck (Cinncinatti, Ohio) provided a state of the venous stent landscape during the 2024 International Vein Congress (IVC; April 18–20) in Miami. The TriHealth...

FlowTriever device found to dramatically improve breathing among intermediate-risk acute pulmonary...

SCVS 2024 saw Zachary AbuRahma, DO, an assistant professor of vascular surgery at West Virginia University and the Charleston Area Medical Center in Charleston,...

CX 2024 venous programme has “a lot to look forward to,”...

Erin Murphy (Atrium Health’s Sanger Heart and Vascular Institute, Charlotte, USA), one of the CX Symposium cochairs and a CX Executive Board member, along...

AngioDynamics receives 510(k) clearance for AlphaVac F1885 System in treatment of...

AngioDynamics has announced that the United States Food and Drug Administration (FDA) has cleared their AlphaVac F1885 system for the treatment of pulmonary embolism...

Novel microbubble-enhanced ultrasound procedure shows promise in acute porcine DVT model...

Evaluation of the safety and performance of a novel pharmaco-mechanical procedure for acute deep vein thrombosis (DVT) in two pigs demonstrated a significant reduction...

Study hints at long-term cost-effectiveness of CDT and PMT over oral...

Anna Pouncey feature
During a presentation at the 2024 European Vascular Course (EVC; March 3–5) in Maastricht, The Netherlands, Anna Pouncey, a clinical research fellow for vascular...

First-in-human study of Pounce thrombectomy system in acute iliofemoral DVT demonstrates...

Twelve-month outcomes from the Pounce venous thrombectomy system (Vetex Medical) first-in-human study evaluating its use in the treatment of acute iliofemoral deep vein thrombosis...

New study reveals how fasting prior to venography shows differences in...

During the 2024 American Venous Forum (AVF) annual meeting in Tampa, Florida (March 3–6), Kurt S. Schultz, MD, a general surgery resident at the...

AVF 2024: Outgoing president addresses history, future direction of American Venous...

At the 2024 American Venous Forum (AVF) in Tampa, Florida (March 3–6), Glenn Jacobowitz, MD, professor of vascular and endovascular surgery at NYU Langone...